上海医药2019年股票期权激励计划预留部分第三个行权期届满,激励对象未行权

中访网数据
Feb 12

中访网数据上海医药集团股份有限公司(证券代码:601607,证券简称:上海医药)于近日公告了其2019年A股股票期权激励计划预留股票期权第三个行权期的自主行权结果。根据公告,该行权期自2025年2月8日起至2026年2月7日止,可行权的股票期权数量为68万份。在规定的行权期内,相关激励对象未行使任何股票期权。随着该行权期于2026年2月7日届满,所有未行权的股票期权将由公司统一办理注销手续。本次...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10